ANDA 70317, held by Rising. Clonidine Hydrochloride.
As of Nov 16, 2026, ANDA 70317 (Clonidine Hydrochloride), held by Rising, was first approved by FDA on Jun 9, 1987, with 8 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jun 9, 1987 | Original application | Approved | None posted |
| Clonidine Hydrochloride0.3MG · tablet;oral | Clonidine Hydrochloride | Discontinued |
| Clonidine Hydrochloride0.1MG · tablet;oral | Clonidine Hydrochloride | Discontinued |
| Clonidine Hydrochloride0.2MG · tablet;oral | Clonidine Hydrochloride | Discontinued |
| Jan 16, 2013 | Supplement 23Labeling · Standard review | Approved | None posted |
| Feb 5, 1998 | Supplement 9Manufacturing | Approved | None posted |
| Jul 15, 1997 | Supplement 8Labeling | Approved | None posted |
| Feb 24, 1995 | Supplement 7Manufacturing | Approved | None posted |
| Oct 1, 1993 | Supplement 5Manufacturing | Approved | None posted |
| Jul 29, 1991 | Supplement 1Manufacturing | Approved | None posted |
| Mar 22, 1991 | Supplement 4Labeling | Approved | None posted |
| Jan 31, 1990 | Supplement 3Manufacturing | Approved | None posted |
| Jun 9, 1987 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters